Literature DB >> 12730086

Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog.

Hartmut Kuhn1, Monika Anton, Christa Gerth, Andreas Habenicht.   

Abstract

OBJECTIVE: The mouse strain CON6, which was generated by breeding athero-resistant CAST mice into an athero-susceptible B6 background, exhibits almost complete resistance to atherosclerosis. An athero-resistance gene cluster has been localized at the central region of chromosome 6, and among the candidate genes of this locus, the 5-lipoxygenase has attracted particular attention because of its involvement in the biosynthesis of proinflammatory leukotrienes. Comparison of 5-lipoxygenase genomic sequences of B6 and CON6 mice indicated 2 conserved amino acid exchanges in the CON6 animals, but the functional impact of these mutations has not been defined. METHODS AND
RESULTS: We analyzed the functionality of these amino acid exchanges relative to essential catalytic properties (specific activity, substrate affinity, and reaction specificity) and found that these mutations confer an impaired lipoxygenase and leukotriene A4-synthase activity when introduced into the human enzyme. In contrast, substrate affinity, enantiomer selectivity, and positional specificity remained unchanged.
CONCLUSIONS: These data are consistent with the possibility that naturally occurring conservative mutations in the coding region of the murine 5-lipoxygenase gene can significantly affect enzyme activity and that this loss of function may be involved in CAST/CON6 athero-resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730086     DOI: 10.1161/01.ATV.0000074167.01184.48

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  4 in total

1.  Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.

Authors:  Qurrat ul Ain; Nigel H Greig; Muhammad S Nawaz; Sajid Rashid; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

2.  The structure of human 5-lipoxygenase.

Authors:  Nathaniel C Gilbert; Sue G Bartlett; Maria T Waight; David B Neau; William E Boeglin; Alan R Brash; Marcia E Newcomer
Journal:  Science       Date:  2011-01-14       Impact factor: 47.728

3.  PPARG by dietary fat interaction influences bone mass in mice and humans.

Authors:  Cheryl L Ackert-Bicknell; Serkalem Demissie; Caralina Marín de Evsikova; Yi-Hsiang Hsu; Victoria E DeMambro; David Karasik; L Adrienne Cupples; Jose M Ordovas; Katherine L Tucker; Kelly Cho; Ernesto Canalis; Beverly Paigen; Gary A Churchill; Jiri Forejt; Wesley G Beamer; Serge Ferrari; Mary L Bouxsein; Douglas P Kiel; Clifford J Rosen
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

Review 4.  Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.

Authors:  Francesca Colazzo; Paolo Gelosa; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-08-28       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.